During the past decade, Associates in Infectious Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Associates in Infectious Diseases" #1 sponsor was "ViiV Healthcare" with 2 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Florida State University" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "TaiMed Biologics Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associates in Infectious Diseases" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Associates in Infectious Diseases" are "HIV Infections" (2 trials), "Evaluate the Relationship Between HIV Medications and Coronary Atherosclerosis" (1 trials), "HIV" (1 trials), "HIV Infection" (1 trials) and "Human Immunodeficiency Virus" (1 trials). Many other conditions were trialed in "Associates in Infectious Diseases" in a lesser frequency.

Most popular intervention types in "Associates in Infectious Diseases" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Ibalizumab" (1 trials), "Maraviroc along with an optimized background antiretroviral drug regimen" (1 trials), "Optimized background antiretroviral drug regimen without maraviroc" (1 trials), "abacavir (ABC)/lamivudine (3TC)" (1 trials) and "emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Associates in Infectious Diseases" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Associates in Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Associates in Infectious Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Associates in Infectious Diseases, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".